{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:42:26Z","timestamp":1794246146486,"version":"4.9.0"},"reference-count":43,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Background:\u00a0People on drug-resistant tuberculosis (DR-TB) treatment face multiple challenges, which include severe disease and treatment side effects, together with psychosocial and socioeconomic challenges. These challenges impact patients\u2019 ability to remain in care and complete their treatment.\nMethods:\u00a0We conducted a scoping review to synthesise evidence on patient-centred care interventions that have been offered to DR-TB patients to facilitate retention in care. Studies published from 2005 until 2023 were retrieved from primary research articles, grey literature and review articles published in peer-reviewed journals.\nResults:\u00a0Among the 347 articles sought for retrieval, 172 were subsequently excluded from the analysis for various reasons. Ultimately, 14 studies met the inclusion criteria, providing valuable insights into patient-centred interventions for DR-TB patients. These interventions aimed to mitigate the complex challenges faced by DR-TB patients during treatment and were categorised into four groups, consistent with the World Health Organization (WHO) recommendations on social support for people with DR-TB: (1) informational, (2) emotional, (3) companionship and (4) material support. Most studies (n\u00a0= 11) offered DR-TB patients integrated forms of support. Material support was the most common form of support utilised across the studies (n\u00a0= 12), followed by informational (n\u00a0= 9), companionship (n\u00a0= 7) and emotional support (n\u00a0= 5).\nConclusion:\u00a0Patient-centred care interventions improve retention in care and treatment outcomes among DR-TB patients.\nContribution:\u00a0The study contributes to the discourse on the value of patient-centred care in managing people with DR-TB.<\/jats:p>","DOI":"10.4102\/safp.v67i1.6180","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:21:46Z","timestamp":1764224506000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient-centred interventions for drug-resistant tuberculosis: A scoping review"],"prefix":"10.4102","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1540-6033","authenticated-orcid":false,"given":"Ndiviwe","family":"Mphothulo","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04qzfn040","id-type":"ROR","asserted-by":"publisher"}],"name":"University of KwaZulu-Natal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9205-9314","authenticated-orcid":false,"given":"Marian","family":"Loveday","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05q60vz69","id-type":"ROR","asserted-by":"publisher"}],"name":"South African Medical Research Council"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9192-1662","authenticated-orcid":false,"given":"Hanlie","family":"Myburg","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05bk57929","id-type":"ROR","asserted-by":"publisher"}],"name":"Stellenbosch University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2025,11,30]]},"reference":[{"key":"ref0","unstructured":"World Health Organisation. Global tuberculosis report 2024. Geneva: World Health Organisation; 2024."},{"key":"ref1","unstructured":"World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization; 2015."},{"key":"ref2","unstructured":"World Health Organisation. Global tuberculosis report 2023. Geneva: World Health Organization; 2023."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Bagcchi S. WHO\u2019s global tuberculosis report 2022. Lancet Microbe. 2023;4(1):e20. https:\/\/doi.org\/10.1016\/S2666-5247(22)00359-7","DOI":"10.1016\/S2666-5247(22)00359-7"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Alagna R, Cabibbe AM, Miotto P, et al. Is the new WHO definition of extensively drug-resistant tuberculosis easy to apply in practice? Eur Respir J. 2021;58(1):2100959. https:\/\/doi.org\/10.1183\/13993003.00959-2021","DOI":"10.1183\/13993003.00959-2021"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Mesfin YM, Hailemariam D, Biadglign S, Kibret KT. Association between HIV\/AIDS and multi-drug resistance tuberculosis: A systematic review and meta-analysis. PLoS One. 2014;9(1):e82235. https:\/\/doi.org\/10.1371\/journal.pone.0082235","DOI":"10.1371\/journal.pone.0082235"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Manjelievskaia J, Erck D, Piracha S, Schrager L. Drug-resistant TB: Deadly, costly and in need of a vaccine. Trans R Soc Trop Med Hyg. 2016;110(3):186\u2013191. https:\/\/doi.org\/10.1093\/trstmh\/trw006","DOI":"10.1093\/trstmh\/trw006"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Wen S, Yin J, Sun Q. Impacts of social support on the treatment outcomes of drug-resistant tuberculosis: A systematic review and meta-analysis. BMJ Open. 2020;10(10):e036985. https:\/\/doi.org\/10.1136\/bmjopen-2020-036985","DOI":"10.1136\/bmjopen-2020-036985"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Tomita A, Ramlall S, Naidu T, Mthembu SS, Padayatchi N, Burns JK. Major depression and household food insecurity among individuals with multidrug-resistant tuberculosis (MDR-TB) in South Africa. Soc Psychiatry Psychiatr Epidemiol. 2019;54:387\u2013393. https:\/\/doi.org\/10.1007\/s00127-019-01669-y","DOI":"10.1007\/s00127-019-01669-y"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Thomas BE, Shanmugam P, Malaisamy M, et al. Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: A systematic review. PLoS One. 2016;11(1):e0147397. https:\/\/doi.org\/10.1371\/journal.pone.0147397","DOI":"10.1371\/journal.pone.0147397"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Soedarsono S, Mertaniasih NM, Kusmiati T, et al. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: The importance of psycho-social and economic aspects. BMC Pulm Med. 2021;21(1):1\u20138. https:\/\/doi.org\/10.1186\/s12890-021-01735-9","DOI":"10.1186\/s12890-021-01735-9"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Sanchez-Padilla E, Marquer C, Kalon S, et al. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: A quantitative and qualitative study. Int J Tuberc Lung Dis. 2014;18(2):160\u2013167. https:\/\/doi.org\/10.5588\/ijtld.13.0369","DOI":"10.5588\/ijtld.13.0369"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Najafizada M, Rahman A, Taufique Q, Sarkar A. Social determinants of multidrug-resistant tuberculosis: A scoping review and research gaps. Indian J Tuberc. 2021;68(1):99\u2013105. https:\/\/doi.org\/10.1016\/j.ijtb.2020.09.016","DOI":"10.1016\/j.ijtb.2020.09.016"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Odone A, Roberts B, Dara M, van den Boom M, Kluge H, McKee M. People- and patient-centred care for tuberculosis: models of care for tuberculosis. Int J Tuberc Lung Dis. 2018 Feb 1;22(2):133\u2013138. https:\/\/doi.org\/10.5588\/ijtld.17.0608. PMID: 29506609.","DOI":"10.5588\/ijtld.17.0608"},{"key":"ref14","unstructured":"World Health Organization. A global action framework for TB research in support of the third pillar of WHO\u2019s end TB strategy. Geneva: World Health Organization; 2015. Report No.: 9241509759."},{"key":"ref15","unstructured":"World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization; 2014."},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: Towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332. https:\/\/doi.org\/10.1080\/1364557032000119616","DOI":"10.1080\/1364557032000119616"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169(7):467\u2013473. https:\/\/doi.org\/10.7326\/M18-0850","DOI":"10.7326\/M18-0850"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst Rev. 2022;18(2):e1230. https:\/\/doi.org\/10.1002\/cl2.1230","DOI":"10.1002\/cl2.1230"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Baral SC, Aryal Y, Bhattrai R, King R, Newell JN. The importance of providing counselling and financial support to patients receiving treatment for multi-drug resistant TB: Mixed method qualitative and pilot intervention studies. BMC Public Health. 2014;14(1):1\u20137. https:\/\/doi.org\/10.1186\/1471-2458-14-46","DOI":"10.1186\/1471-2458-14-46"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Acha J, Sweetland A, Guerra D, Chalco K, Castillo H, Palacios E. Psychosocial support groups for patients with multidrug-resistant tuberculosis: Five years of experience. Glob Public Health. 2007;2(4):404\u2013417. https:\/\/doi.org\/10.1080\/17441690701191610","DOI":"10.1080\/17441690701191610"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Bhatt R, Chopra K, Vashisht R. Impact of integrated psycho-socio-economic support on treatment outcome in drug resistant tuberculosis \u2013 A retrospective cohort study. Indian J Tuberc. 2019;66(1):105\u2013110. https:\/\/doi.org\/10.1016\/j.ijtb.2018.05.020","DOI":"10.1016\/j.ijtb.2018.05.020"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Brust JC, Shah NS, Scott M, et al. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: An alternate model of care [perspectives]. Int J Tuberc Lung Dis. 2012;16(8):998\u20131004. https:\/\/doi.org\/10.5588\/ijtld.11.0713","DOI":"10.5588\/ijtld.11.0713"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Gelmanova I, Taran D, Mishustin S, Golubkov A, Solovyova A, Keshavjee S. \u2018Sputnik\u2019: A programmatic approach to improve tuberculosis treatment adherence and outcome among defaulters. Int J Tuberc Lung Dis. 2011;15(10):1373\u20131379. https:\/\/doi.org\/10.5588\/ijtld.10.0531","DOI":"10.5588\/ijtld.10.0531"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Taneja N, Chellaiyan VG, Daral S, Adhikary M, Das TK. Home based care as an approach to improve the efficiency of treatment for MDR tuberculosis: A quasi-experimental pilot study. J Clin Diagn Res. 2017;11(8):LC05. https:\/\/doi.org\/10.7860\/JCDR\/2017\/27594.10401","DOI":"10.7860\/JCDR\/2017\/27594.10401"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Li R, Ruan Y, Sun Q, et al. Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: A before-and-after study. Lancet Glob Health. 2015;3(4):e217\u2013e228. https:\/\/doi.org\/10.1016\/S2214-109X(15)70021-5","DOI":"10.1016\/S2214-109X(15)70021-5"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Chan P-C, Huang S-H, Yu M-C, et al. Effectiveness of a government-organized and hospital-initiated treatment for multidrug-resistant tuberculosis patients-a retrospective cohort study. PLoS One. 2013;8(2):e57719. https:\/\/doi.org\/10.1371\/journal.pone.0057719","DOI":"10.1371\/journal.pone.0057719"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Mohr E, Daniels J, Beko B, et al. DOT or SAT for rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting. PLoS One. 2017;12(5):e0178054. https:\/\/doi.org\/10.1371\/journal.pone.0178054","DOI":"10.1371\/journal.pone.0178054"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Oyieng\u2019o D, Park P, Gardner A, et al. Community-based treatment of multidrug-resistant tuberculosis: Early experience and results from Western Kenya. Public Health Action. 2012;2(2):38\u201342. https:\/\/doi.org\/10.5588\/pha.12.0002","DOI":"10.5588\/pha.12.0002"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Yin J, Wang X, Zhou L, Wei X. The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in China: A mixed-methods study. Trop Med Int Health. 2018;23(6):668\u2013677. https:\/\/doi.org\/10.1111\/tmi.13066","DOI":"10.1111\/tmi.13066"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Sripad A, Castedo J, Danford N, Zaha R, Freile C. Effects of Ecuador\u2019s national monetary incentive program on adherence to treatment for drug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014;18(1):44\u201348. https:\/\/doi.org\/10.5588\/ijtld.13.0253","DOI":"10.5588\/ijtld.13.0253"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Bhargava A, Bhargava M, Velayutham B, et al. The RATIONS (Reducing Activation of Tuberculosis by Improvement of Nutritional Status) study: A cluster randomised trial of nutritional support (food rations) to reduce TB incidence in household contacts of patients with microbiologically confirmed pulmonary tuberculosis in communities with a high prevalence of undernutrition, Jharkhand, India. BMJ Open. 2021;11(5):e047210. https:\/\/doi.org\/10.1136\/bmjopen-2020-047210","DOI":"10.1136\/bmjopen-2020-047210"},{"key":"ref32","unstructured":"Kunawararak P, Pongpanich S, Chantawong S, et al. Tuberculosis treatment with mobile-phone medication reminders in northern Thailand. Southeast Asian J Trop Med Public Health. 2011;42(6): 1444."},{"key":"ref33","unstructured":"Higgins J, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Oxford: Cochrane Collaboration and John Wiley & Sons Ltd; 2021."},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Lutge E, Lewin S, Volmink J, Friedman I, Lombard C. Economic support to improve tuberculosis treatment outcomes in South Africa: A pragmatic cluster-randomized controlled trial. Trials. 2013;14:1\u201313.","DOI":"10.1186\/1745-6215-14-154"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Lutge E, Lewin S, Volmink J. Economic support to improve tuberculosis treatment outcomes in South Africa: A qualitative process evaluation of a cluster randomized controlled trial. Trials. 2014;15:1\u201312. https:\/\/doi.org\/10.1186\/1745-6215-15-236","DOI":"10.1186\/1745-6215-15-236"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Lutge EE, Wiysonge CS, Knight SE, Sinclair D, Volmink J. Incentives and enablers to improve adherence in tuberculosis. Cochrane Database Syst Rev. 2015;2015(9):Cd007952. https:\/\/doi.org\/10.1002\/14651858.CD007952.pub3","DOI":"10.1002\/14651858.CD007952.pub3"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Boccia D, Pedrazzoli D, Wingfield T, et al. Towards cash transfer interventions for tuberculosis prevention, care and control: Key operational challenges and research priorities. BMC Infect Dis. 2016;16(1):307. https:\/\/doi.org\/10.1186\/s12879-016-1529-8","DOI":"10.1186\/s12879-016-1529-8"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Wells C, Severn M. Incentives and support programs to improve adherence to tuberculosis treatment. Can J Health Technol. 2021;1(2):1\u201371. https:\/\/doi.org\/10.51731\/cjht.2021.35","DOI":"10.51731\/cjht.2021.35"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Bhargava A, Bhargava M, Pai M. Tuberculosis: A biosocial problem that requires biosocial solutions. Lancet. 2024;403(10443):2467\u20132469. https:\/\/doi.org\/10.1016\/S0140-6736(24)00489-6","DOI":"10.1016\/S0140-6736(24)00489-6"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Samuel B, Volkmann T, Cornelius S, et al. Relationship between nutritional support and tuberculosis treatment outcomes in West Bengal, India. J Tuberc Res. 2016;4(4):213. https:\/\/doi.org\/10.4236\/jtr.2016.44023","DOI":"10.4236\/jtr.2016.44023"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Wagnew F, Alene KA, Kelly M, Gray D. The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: A systematic review and meta-analysis. Int J Infect Dis. 2023;127:93\u2013105. https:\/\/doi.org\/10.1016\/j.ijid.2022.11.043","DOI":"10.1016\/j.ijid.2022.11.043"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Sinha P, Davis J, Saag L, et al. Undernutrition and tuberculosis: Public health implications. J Infect Dis. 2019;219(9):1356\u20131363. https:\/\/doi.org\/10.1093\/infdis\/jiy675","DOI":"10.1093\/infdis\/jiy675"}],"container-title":["South African Family Practice"],"original-title":[],"link":[{"URL":"https:\/\/safpj.co.za\/index.php\/safpj\/article\/view\/6180\/9964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:21:51Z","timestamp":1764224511000},"score":1,"resource":{"primary":{"URL":"https:\/\/safpj.co.za\/index.php\/safpj\/article\/view\/6180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.4102\/safp.v67i1.6180","relation":{},"ISSN":["2078-6190","2078-6204"],"issn-type":[{"value":"2078-6190","type":"print"},{"value":"2078-6204","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,30]]},"article-number":"a6180"}}